+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alopecia Drug"

From
Alopecia Drugs - Global Strategic Business Report - Product Thumbnail Image

Alopecia Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 187 Pages
  • Global
From
Alopecia Market Report 2025 - Product Thumbnail Image

Alopecia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
From
From
Androgenetic Alopecia Treatment Global Market Report 2024 - Product Thumbnail Image

Androgenetic Alopecia Treatment Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Androgenic Alopecia: Competitive Landscape - Product Thumbnail Image

Androgenic Alopecia: Competitive Landscape

  • Report
  • May 2024
  • 72 Pages
  • Global
From
Alopecia Areata - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia Areata - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Alopecia Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Alopecia Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics. The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more